What is the 13F Pro Quality Score for HNGE?

13F Pro ranks Hinge Health, Inc. (HNGE) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View HNGE's current score at https://13fpro.ai/company/HNGE (free sign-up required for the full ranking).

Where does 13F Pro source HNGE data?

All Hinge Health, Inc. fundamentals and ownership data come directly from SEC EDGAR. Hinge Health, Inc. files with the SEC under CIK 1673743. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is HNGE in?

Hinge Health, Inc. (HNGE) is classified in the Technology sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/technology.

What drives HNGE's revenue?

Per Hinge Health, Inc.'s latest 10-Q filed with the SEC on 2026-08-06, the biggest revenue drivers are: Member subscription revenue (one reportable segment) ($212.8M, +53% YoY); Recognized from beginning-of-period deferred revenue ($171.2M). Figures are extracted from the filing text and machine-verified against the document. Full breakdown at https://13fpro.ai/company/HNGE.

What are HNGE's largest expenses?

Hinge Health, Inc.'s latest 10-Q reports these as the largest expense items: Sales and marketing ($81.4M, -45% YoY); Research and development ($34.1M, -88% YoY); Cost of revenue ($28.9M, -30% YoY). Sourced directly from SEC EDGAR filing text for Q2 2026 (quarter ended June 30, 2026).

How often is HNGE research updated on 13F Pro?

HNGE's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Hinge Health, Inc.(HNGE)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Technology →NYSEmid

Institutional-grade research for retail investors

SEC EDGAR: CIK 1673743 HNGE stock profile & AI dashboard →

13F Pro Quality Score

74.9/100

Rank #105 of 2,961 stocksTOP 5%

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

85.2/100

Profitability

79.3/100

Balance Sheet

92.1/100

Earnings Quality

77.7/100

Free Cash Flow

90.9/100

Institutional Flow

80.1/100

Revenue Scale

43.4/100

Dilution Risk

3.0/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why HNGE Scores 75/100

exact factor attribution · 2026-09-11

HNGE's composite is driven by revenue growth and free cash flow, held back by shareholder dilution. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Revenue growth

+7.0 pts

85th pct

Free cash flow

+6.1 pts

91th pct

Profitability

+4.4 pts

79th pct

Capital efficiency

+4.2 pts

92th pct

Earnings quality

+2.8 pts

78th pct

Earnings growth

+2.1 pts

93th pct

Institutional flow

+1.5 pts

80th pct

Scale

-1.0 pts

43th pct

Shareholder dilution

-2.4 pts

3th pct

Latest change (2026-08-06): 45 → 66 · ↑ Profit margin 30→81; ↑ Capital efficiency 30→89

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

Unusual Activity in HNGE

Events flagged as statistical outliers against HNGE's own multi-year baseline — not fixed dollar thresholds.

Score shock2026-08-06
HNGE quality score jumped 21 points (45→66) on a new filing
View source filing →

HNGE Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for Hinge Health, Inc. (HNGE), a Technology sector company. 13F Pro's AI-powered ranking engine scores HNGE at 74.9/100 on a 32-signal composite quality model, placing it at rank #105 of 2,961 stocks — the top 5% of the AI-ranked universe. HNGE scores in the top quartile across balance sheet strength (92.1), free cash flow (90.9), revenue growth (85.2). Shareholder dilution risk is elevated at 3.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Hinge Health, Inc. reports quarterly revenue of $212.8M, net income of $43.7M, free cash flow of $101.3M. Top institutional holders of HNGE by reported 13-F value include BlackRock, 11.2 Capital Management, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. HNGE trades on the NYSE exchange and files with the SEC under CIK 1673743. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HNGE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Hinge Health, Inc. directly from SEC EDGAR. Hinge Health, Inc.'s 13F Pro composite quality score has ranged between 29 and 75 since 2026, currently 74.9 — an improving long-term trajectory across 43 quarterly and live scoring snapshots.

What's Driving HNGE's Business? Latest 10-Q Breakdown

✓ 43/43 datapoints verified

AI-extracted from Hinge Health, Inc.'s 10-Q filed 2026-08-06 — Q2 2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Q2 revenue rose 53% to $212.8M with gross margin up 16 points to 86%, producing $43.7M net income versus a $575.7M IPO-charge loss a year ago.

Biggest Revenue Drivers

Member subscription revenue (one reportable segment)$212.8M+53% YoY

Increase primarily due to revenue growth from existing clients, from retaining members within and adding more members to the existing member base

Biggest Revenue Drivers

Total revenue: $212.8M+53% YoY

Member subscription revenue (one reportable segment)$212.8M+53% YoY

Increase primarily due to revenue growth from existing clients, from retaining members within and adding more members to the existing member base

Within Member subscription revenue (one reportable segment)

Recognized from beginning-of-period deferred revenue$171.2M

Revenue recognized during the quarter that was included in the deferred revenue balance at the beginning of the period

Largest Expense Items

Sales and marketing$81.4M-45% YoY

$89.1M lower stock-based compensation tied to IPO vesting, offset by $13.3M more marketing and promotion and $9.5M more commissions

Research and development$34.1M-88% YoY

$241.7M decrease in stock-based compensation from RSU/PRSU vesting criteria met at the 2025 IPO, offset by $1.8M higher IT costs

Cost of revenue$28.9M-30% YoY

$15.3M lower stock-based compensation, partly offset by $2.9M higher inventory costs (net of a $1.7M tariff refund) and $1.4M hosting

General and administrative$28.0M-89% YoY

$225.8M lower stock-based compensation, offset by $4.5M higher legal and other costs supporting public company compliance

Margins: Gross margin rose 16 percentage points to 86% from 70%, primarily due to lower stock-based compensation and greater care team operating efficiencies. Non-GAAP operating margin reached 29% versus 19%.

Watch Items from the Filing

Partner concentration: contracts through partners were 85% of six-month revenue; HCSC 15%, Elevance 13%, Aetna 10%. Partners are non-exclusive and may terminate for convenience.
Deferred revenue grew to $416.5M from $300.9M at year-end, and LTM calculated billings reached $861.8M versus $568.4M a year earlier.
Announced August 4, 2026 definitive agreement to acquire Cylinder Health for $105 million cash, expected to close in the third quarter of 2026.
Founder PRSU settlements triggered roughly $37.9M and $39.6M of company cash outlays for tax withholding in the third quarter of 2026.
Repurchased $196.5M of Class A stock through July 29, 2026; board raised total authorization to $496.5M, with $300.0M remaining available.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →Share on X

Revenue

Q2 2026

$212.8M

Net Income

Q2 2026

$43.7M

Free Cash Flow

Q2 2026

$101.3M

ROIC

Q2 2026

47.0%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+50.6% YoY

$587.9MFY 2025

FY22 —FY23 $292.7MFY24 $390.4MFY25 $587.9M

Net Income

-4326.9% YoY

$-528.3MFY 2025

FY22 —FY23 $-108.1MFY24 $-11.9MFY25 $-528.3M

Operating Income

-1612.2% YoY

$-546.4MFY 2025

FY22 —FY23 $-130.5MFY24 $-31.9MFY25 $-546.4M

EPS (Diluted)

-783.0% YoY

$-7.77FY 2025

FY22 —FY23 $-8.31FY24 $-0.88FY25 $-7.77

Total Assets

+10.6% YoY

$744.8MFY 2025

FY22 —FY23 —FY24 $673.3MFY25 $744.8M

Op. Cash Flow

+249.9% YoY

$171.4MFY 2025

FY22 —FY23 $-63.9MFY24 $49.0MFY25 $171.4M

Free Cash Flow

+256.0% YoY

$170.7MFY 2025

FY22 —FY23 $-65.9MFY24 $48.0MFY25 $170.7M

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Revenue	$587.9M +50.6%	$390.4M +33.4%	$292.7M	—
Net Income	$-528.3M -4326.9%	$-11.9M +89.0%	$-108.1M	—
Operating Income	$-546.4M -1612.2%	$-31.9M +75.6%	$-130.5M	—
EPS (Diluted)	$-7.77 -783.0%	$-0.88 +89.4%	$-8.31	—
Total Assets	$744.8M +10.6%	$673.3M	—	—
Operating Cash Flow	$171.4M +249.9%	$49.0M +176.7%	$-63.9M	—
Free Cash Flow	$170.7M +256.0%	$48.0M +172.8%	$-65.9M	—

Get alerted when HNGE's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Hinge Health, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of HNGE

BlackRock, Inc.
$296.3M3,570,131 sh
11.2 Capital Management, LLC
$204.6M2,464,657 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$178.1M2,146,032 sh
Deer Management Co. LLC
$158.4M1,908,707 sh
VANGUARD CAPITAL MANAGEMENT LLC
$157.1M1,892,834 sh
TWO SIGMA INVESTMENTS, LP
$150.1M1,807,895 sh
FULLER & THALER ASSET MANAGEMENT, INC.
$142.1M1,712,507 sh
MORGAN STANLEY
$134.0M1,613,901 sh
FRANKLIN RESOURCES INC
$131.1M1,579,056 sh
JANE STREET GROUP, LLC
$117.7M1,418,317 sh

Fund	Value	Shares
BlackRock, Inc.	$296.3M	3,570,131
11.2 Capital Management, LLC	$204.6M	2,464,657
VANGUARD PORTFOLIO MANAGEMENT LLC	$178.1M	2,146,032
Deer Management Co. LLC	$158.4M	1,908,707
VANGUARD CAPITAL MANAGEMENT LLC	$157.1M	1,892,834
TWO SIGMA INVESTMENTS, LP	$150.1M	1,807,895
FULLER & THALER ASSET MANAGEMENT, INC.	$142.1M	1,712,507
MORGAN STANLEY	$134.0M	1,613,901
FRANKLIN RESOURCES INC	$131.1M	1,579,056
JANE STREET GROUP, LLC	$117.7M	1,418,317

Companies Similar to HNGE

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

RMBS

RAMBUS INC

AI score

Similar quality profile · 15 shared holders

OBERWEIS ASSET MANAGEMENT INC/Shannon River Fund Management LLC LOOMIS SAYLES & CO L P

FORM

FORMFACTOR INC

AI score

Similar quality profile · 18 shared holders

FULLER & THALER ASSET MANAGEMENT, INC.OBERWEIS ASSET MANAGEMENT INC/First Eagle Investment Management, LLC

YOU

Clear Secure, Inc.

AI score

Similar quality profile · 17 shared holders

LORD, ABBETT & CO. LLC Divisadero Street Capital Management, LP JACOBS LEVY EQUITY MANAGEMENT, INC

AGYS

AGILYSYS INC

AI score

Similar quality profile · 12 shared holders

EMERALD ADVISERS, LLC LOOMIS SAYLES & CO L P BAMCO INC /NY/

DOCS

Doximity, Inc.

AI score

Similar quality profile · 10 shared holders

LOOMIS SAYLES & CO L P Voleon Capital Management LP ING GROEP NV

GRND

Grindr Inc.

AI score

Similar quality profile · 8 shared holders

JACOBS LEVY EQUITY MANAGEMENT, INC Susquehanna Portfolio Strategies, LLC BIT Capital GmbH

ALAB

Astera Labs, Inc.

AI score

Similar quality profile · 9 shared holders

FULLER & THALER ASSET MANAGEMENT, INC.ALKEON CAPITAL MANAGEMENT LLC LORD, ABBETT & CO. LLC

CRDO

Credo Technology Group Holding Ltd

AI score

Similar quality profile · 9 shared holders

FULLER & THALER ASSET MANAGEMENT, INC.OBERWEIS ASSET MANAGEMENT INC/LORD, ABBETT & CO. LLC

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Technology Companies

View all Technology →

AGILENT TECHNOLOGIES, INC.

AAOI

APPLIED OPTOELECTRONICS, INC.

AAPL

Apple Inc.

ABNB

Airbnb, Inc.

ACCL

Acco Group Holdings Ltd

ACCS

ACCESS Newswire Inc.

ACFN

ACORN ENERGY, INC.

ACIW

ACI WORLDWIDE, INC.

Put HNGE on your watchlist

Track score changes the day Hinge Health, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is HNGE a good stock to buy?

13F Pro's AI-powered analysis of Hinge Health, Inc. (HNGE) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for HNGE are available on the HNGE stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. HNGE is classified as a mid company.

Which hedge funds own HNGE?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling HNGE. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Hinge Health, Inc.'s investment landscape.